In last trading session, 89bio Inc (NASDAQ:ETNB) saw 2.53 million shares changing hands with its beta currently measuring 1.43. Company’s recent per share price level of $8.20 trading at $0.4 or 5.13% at ring of the bell on the day assigns it a market valuation of $1.20B. That closing price of ETNB’s stock is at a discount of -44.39% from its 52-week high price of $11.84 and is indicating a premium of 49.27% from its 52-week low price of $4.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.75 million shares which gives us an average trading volume of 1.87 million if we extend that period to 3-months.
For 89bio Inc (ETNB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.36. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
89bio Inc (NASDAQ:ETNB) trade information
Upright in the green during last session for gaining 5.13%, in the last five days ETNB remained trading in the green while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $8.20 price level, adding 2.96% to its value on the day. 89bio Inc’s shares saw a change of 4.86% in year-to-date performance and have moved 6.91% in past 5-day. 89bio Inc (NASDAQ:ETNB) showed a performance of 38.51% in past 30-days. Number of shares sold short was 17.31 million shares which calculate 9.2 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 25 to the stock, which implies a rise of 67.2% to its current value. Analysts have been projecting 12 as a low price target for the stock while placing it at a high target of 29. It follows that stock’s current price would drop -46.34% in reaching the projected high whereas dropping to the targeted low would mean a loss of -46.34% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 32.21% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 41.04% while estimates for its earnings growth in next 5 years are of 16.04%.
89bio Inc (NASDAQ:ETNB)’s Major holders
Insiders are in possession of 0.63% of company’s total shares while institution are holding 106.55 percent of that, with stock having share float percentage of 107.23%. Investors also watch the number of corporate investors in a company very closely, which is 106.55% institutions for 89bio Inc that are currently holding shares of the company. RA CAPITAL MANAGEMENT, L.P. is the top institutional holder at ETNB for having 14.18 million shares of worth $113.54 million. And as of 2024-06-30, it was holding 14.1994 of the company’s outstanding shares.
The second largest institutional holder is JANUS HENDERSON GROUP PLC, which was holding about 13.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.2986 of outstanding shares, having a total worth of $106.32 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 3.08 shares of worth $25.25 million or 2.11% of the total outstanding shares. The later fund manager was in possession of 2.97 shares on Mar 31, 2025 , making its stake of worth around $24.34 million in the company or a holder of 2.03% of company’s stock.
